Imperial College London

Dr David R Owen MD PhD

Faculty of MedicineDepartment of Brain Sciences

Reader in Molecular Pharmacology and Experimental Medicine
 
 
 
//

Contact

 

+44 (0)20 3313 6195d.owen Website

 
 
//

Location

 

G20AICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Guo:2012:10.1016/j.neuroimage.2011.12.078,
author = {Guo, Q and Owen, DR and Rabiner, EA and Turkheimer, FE and Gunn, RN},
doi = {10.1016/j.neuroimage.2011.12.078},
journal = {Neuroimage},
pages = {902--910},
title = {Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo},
url = {http://dx.doi.org/10.1016/j.neuroimage.2011.12.078},
volume = {60},
year = {2012}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - To date, (1)(1)C-(R)-PK11195 has been the most widely used TSPO PET imaging probe, although it suffers from high non-specific binding and low signal to noise. A significant number of 2nd generation TSPO radioligands have been developed with higher affinity and/or lower non-specific binding, however there is substantial inter-subject variation in their affinity for the TSPO. TSPO from human tissue samples binds 2nd generation TSPO radioligands with either high affinity (high affinity binders, HABs), or low affinity (LABs) or expresses both HAB and LAB binding sites (mixed affinity binders, MABs). The expression of these different TSPO binding sites in human is encoded by the rs6971 polymorphism in the TSPO gene. Here, we use a predictive biomathematical model to estimate the in vivo performances of three of these 2nd generation radioligands ((1)(8)F-PBR111, (1)(1)C-PBR28, (1)(1)C-DPA713) and (1)(1)C-(R)-PK11195 in humans. The biomathematical model only relies on in silico, in vitro and genetic data (polymorphism frequencies in different ethnic groups) to predict the radioactivity time course in vivo. In particular, we provide estimates of the performances of these ligands in within-subject (e.g. longitudinal studies) and between-subject (e.g. disease characterisation) PET studies, with and without knowledge of the TSPO binding class. This enables an assessment of the different radioligands prior to radiolabelling or acquisition of any in vivo data. The within-subject performance was characterised in terms of the reproducibility of the in vivo binding potential (%COV[BP(ND)]) for each separate TSPO binding class in normal and diseased states (50% to 400% increase in TSPO density), whilst the between-subject performance was characterised in terms of the number of subjects required to distinguish between different populations. The results indicated that the within-subject variability for (1)(8)F-PBR111, (1)(1)C-PBR28 and (1)(1)C-DPA713 (0.9% to 2.2%) was significantly l
AU - Guo,Q
AU - Owen,DR
AU - Rabiner,EA
AU - Turkheimer,FE
AU - Gunn,RN
DO - 10.1016/j.neuroimage.2011.12.078
EP - 910
PY - 2012///
SN - 1095-9572
SP - 902
TI - Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo
T2 - Neuroimage
UR - http://dx.doi.org/10.1016/j.neuroimage.2011.12.078
UR - http://www.ncbi.nlm.nih.gov/pubmed/22251896
VL - 60
ER -